Rotavirus replication is correlated with S/G2 interphase arrest of the host cell cycle

PLoS One. 2017 Jun 16;12(6):e0179607. doi: 10.1371/journal.pone.0179607. eCollection 2017.

Abstract

In infected cells rotavirus (RV) replicates in viroplasms, cytosolic structures that require a stabilized microtubule (MT) network for their assembly, maintenance of the structure and perinuclear localization. Therefore, we hypothesized that RV could interfere with the MT-breakdown that takes place in mitosis during cell division. Using synchronized RV-permissive cells, we show that RV infection arrests the cell cycle in S/G2 phase, thus favoring replication by improving viroplasms formation, viral protein translation, and viral assembly. The arrest in S/G2 phase is independent of the host or viral strain and relies on active RV replication. RV infection causes cyclin B1 down-regulation, consistent with blocking entry into mitosis. With the aid of chemical inhibitors, the cytoskeleton network was linked to specific signaling pathways of the RV-induced cell cycle arrest. We found that upon RV infection Eg5 kinesin was delocalized from the pericentriolar region to the viroplasms. We used a MA104-Fucci system to identify three RV proteins (NSP3, NSP5, and VP2) involved in cell cycle arrest in the S-phase. Our data indicate that there is a strong correlation between the cell cycle arrest and RV replication.

MeSH terms

  • Animals
  • Cyclin B1 / metabolism
  • Cytoskeleton / metabolism
  • Cytoskeleton / virology
  • Dogs
  • G2 Phase Cell Cycle Checkpoints*
  • HEK293 Cells
  • Humans
  • Kinesins / metabolism
  • Macaca mulatta
  • Madin Darby Canine Kidney Cells
  • Rotavirus / physiology*
  • S Phase Cell Cycle Checkpoints*
  • Signal Transduction*
  • Viral Proteins / metabolism
  • Virus Replication / physiology*

Substances

  • CCNB1 protein, human
  • Cyclin B1
  • KIF11 protein, human
  • Viral Proteins
  • Kinesins

Grants and funding

This work was supported by a private donation of the late Prof. Dr. Robert Wyler to M.A. (F-52601-10-01) as well as by general funds allocated to M.A. by the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.